These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 34337623)

  • 1. A new lateral flow assay to detect sIL-2R during T-cell mediated rejection after kidney transplantation.
    Seiler LK; Jonczyk R; Lindner P; Phung NL; Falk CS; Kaufeld J; Gwinner W; Scheffner I; Immenschuh S; Blume C
    Analyst; 2021 Sep; 146(17):5369-5379. PubMed ID: 34337623
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Significance of revised criteria for chronic active T cell-mediated rejection in the 2017 Banff classification: Surveillance by 1-year protocol biopsies for kidney transplantation.
    Nakagawa K; Tsuchimoto A; Ueki K; Matsukuma Y; Okabe Y; Masutani K; Unagami K; Kakuta Y; Okumi M; Nakamura M; Nakano T; Tanabe K; Kitazono T;
    Am J Transplant; 2021 Jan; 21(1):174-185. PubMed ID: 32484280
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Disappearance of T Cell-Mediated Rejection Despite Continued Antibody-Mediated Rejection in Late Kidney Transplant Recipients.
    Halloran PF; Chang J; Famulski K; Hidalgo LG; Salazar ID; Merino Lopez M; Matas A; Picton M; de Freitas D; Bromberg J; Serón D; Sellarés J; Einecke G; Reeve J
    J Am Soc Nephrol; 2015 Jul; 26(7):1711-20. PubMed ID: 25377077
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Novel urinary exosomal biomarkers of acute T cell-mediated rejection in kidney transplant recipients: A cross-sectional study.
    Lim JH; Lee CH; Kim KY; Jung HY; Choi JY; Cho JH; Park SH; Kim YL; Baek MC; Park JB; Kim YH; Chung BH; Lee SH; Kim CD
    PLoS One; 2018; 13(9):e0204204. PubMed ID: 30226858
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Urinary metabolomics for noninvasive detection of borderline and acute T cell-mediated rejection in children after kidney transplantation.
    Blydt-Hansen TD; Sharma A; Gibson IW; Mandal R; Wishart DS
    Am J Transplant; 2014 Oct; 14(10):2339-49. PubMed ID: 25138024
    [TBL] [Abstract][Full Text] [Related]  

  • 6. PIRCHE-II scores prove useful as a predictive biomarker among kidney transplant recipients with rejection: An analysis of indication and follow-up biopsies.
    Spitznagel T; Matter LS; Kaufmann YL; Nilsson J; von Moos S; Schachtner T
    Front Immunol; 2022; 13():949933. PubMed ID: 36059499
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Urinary cell mRNA profiling of kidney allograft recipients: Development of a portable protocol for noninvasive diagnosis of T cell mediated rejection and BK virus nephropathy.
    Salinas T; Li C; Snopkowski C; Stryjniak G; Shankaranarayanan D; Albakry S; Ding R; Sharma VK; Salvatore SP; Seshan SV; Dadhania DM; Muthukumar T; Suthanthiran M
    J Immunol Methods; 2023 Jan; 512():113402. PubMed ID: 36493873
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Spectrum of Histopathological Changes in the Renal Allograft - a 12 Months Protocol Biopsy Study.
    Severova-Andreevska G; Grcevska L; Petrushevska G; Cakalaroski K; Sikole A; Stojceva-Taneva O; Danilovska I; Ivanovski N
    Open Access Maced J Med Sci; 2018 Apr; 6(4):606-612. PubMed ID: 29731924
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Development of a multivariable gene-expression signature targeting T-cell-mediated rejection in peripheral blood of kidney transplant recipients validated in cross-sectional and longitudinal samples.
    Christakoudi S; Runglall M; Mobillo P; Tsui TL; Duff C; Domingo-Vila C; Kamra Y; Delaney F; Montero R; Spiridou A; Kassimatis T; Phin-Kon S; Tucker B; Farmer C; Strom TB; Lord GM; Rebollo-Mesa I; Stahl D; Sacks S; Hernandez-Fuentes MP; Chowdhury P
    EBioMedicine; 2019 Mar; 41():571-583. PubMed ID: 30833191
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An Antibody-Aptamer-Hybrid Lateral Flow Assay for Detection of CXCL9 in Antibody-Mediated Rejection after Kidney Transplantation.
    Seiler LK; Phung NL; Nikolin C; Immenschuh S; Erck C; Kaufeld J; Haller H; Falk CS; Jonczyk R; Lindner P; Thoms S; Siegl J; Mayer G; Feederle R; Blume CA
    Diagnostics (Basel); 2022 Jan; 12(2):. PubMed ID: 35204399
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Impact of Early Clinical and Subclinical T Cell-mediated Rejection After Kidney Transplantation.
    Hoffman W; Mehta R; Jorgensen DR; Sood P; Randhawa P; Wu CM; Puttarajappa C; Shah NA; Tevar AD; Hariharan S
    Transplantation; 2019 Jul; 103(7):1457-1467. PubMed ID: 30747837
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evolution of renal function and urinary biomarker indicators of inflammation on serial kidney biopsies in pediatric kidney transplant recipients with and without rejection.
    Mincham CM; Gibson IW; Sharma A; Wiebe C; Mandal R; Rush D; Nickerson P; Ho J; Wishart DS; Blydt-Hansen TD
    Pediatr Transplant; 2018 Aug; 22(5):e13202. PubMed ID: 29696778
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A Noninvasive Urine Metabolome Panel as Potential Biomarkers for Diagnosis of T Cell-Mediated Renal Transplant Rejection.
    Kalantari S; Chashmniam S; Nafar M; Samavat S; Rezaie D; Dalili N
    OMICS; 2020 Mar; 24(3):140-147. PubMed ID: 32176594
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Soluble interleukin-2 receptor (sIL-2R) levels in renal transplantation: comparison between clinical and laboratory analysis.
    Montagnino G; Tarantino A; Grignani S; Braga M; Ponticelli C
    Clin Transplant; 1995 Feb; 9(1):25-30. PubMed ID: 7742579
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Investigation of Serum Angiotensin II Type 1 Receptor Antibodies at the Time of Renal Allograft Rejection.
    Lee H; Kim JI; Moon IS; Chung BH; Yang CW; Kim Y; Han K; Oh EJ
    Ann Lab Med; 2015 May; 35(3):314-20. PubMed ID: 25932439
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Soluble interleukin 2 receptor (sIL-2R) levels in renal transplant recipients.
    Mehta R; Shah G; Adler W; Kittur D
    Clin Transplant; 2004; 18 Suppl 12():67-71. PubMed ID: 15217411
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Early surveillance biopsy utilization and management of pediatric renal allograft acute T cell-mediated rejection in Canadian centers: Observations from the PROBE multicenter cohort study.
    Hoffmann AJ; Gibson IW; Ho J; Nickerson P; Rush D; Sharma A; Wishart D; Blydt-Hansen TD
    Pediatr Transplant; 2021 Mar; 25(2):e13870. PubMed ID: 33026135
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serum soluble interleukin 2 receptor (sIL-2R) as a marker of acute rejection in renal transplant children.
    García-Roca P; Vargas YA; Fuentes Y; Hernández AM; Ortiz L; Valverde S; Velásquez-Jones L; Romero-Navarro B; Ramón-Garcia G; Medeiros M
    Pediatr Transplant; 2012 May; 16(3):274-9. PubMed ID: 22309031
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Urinary Metabolomics for Noninvasive Detection of Antibody-Mediated Rejection in Children After Kidney Transplantation.
    Blydt-Hansen TD; Sharma A; Gibson IW; Wishart DS; Mandal R; Ho J; Nickerson P; Rush D
    Transplantation; 2017 Oct; 101(10):2553-2561. PubMed ID: 28121909
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long-term kidney allograft survival in patients with transplant glomerulitis.
    Nabokow A; Dobronravov VA; Khrabrova M; Gröne HJ; Gröne E; Hallensleben M; Kieneke D; Weithofer P; Smirnov AV; Kliem V
    Transplantation; 2015 Feb; 99(2):331-9. PubMed ID: 25594551
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.